1132 related articles for article (PubMed ID: 15645517)
1. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
[TBL] [Abstract][Full Text] [Related]
2. Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.
Perreault S; Dragomir A; Blais L; Moride Y; Rossignol M; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):248-59. PubMed ID: 18213734
[TBL] [Abstract][Full Text] [Related]
3. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
4. Initiation of osteoporosis treatment after bone mineral density testing.
Pressman A; Forsyth B; Ettinger B; Tosteson AN
Osteoporos Int; 2001; 12(5):337-42. PubMed ID: 11444079
[TBL] [Abstract][Full Text] [Related]
5. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
6. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
[TBL] [Abstract][Full Text] [Related]
7. Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.
Kaptoge S; Benevolenskaya LI; Bhalla AK; Cannata JB; Boonen S; Falch JA; Felsenberg D; Finn JD; Nuti R; Hoszowski K; Lorenc R; Miazgowski T; Jajic I; Lyritis G; Masaryk P; Naves-Diaz M; Poor G; Reid DM; Scheidt-Nave C; Stepan JJ; Todd CJ; Weber K; Woolf AD; Roy DK; Lunt M; Pye SR; O'neill TW; Silman AJ; Reeve J
Bone; 2005 Mar; 36(3):387-98. PubMed ID: 15777673
[TBL] [Abstract][Full Text] [Related]
8. Prescriptions for vitamin D among patients taking antiresorptive agents in Canada.
Hanley DA; Zhang Q; Meilleur MC; Mavros P; Sen SS
Curr Med Res Opin; 2007 Jun; 23(6):1473-80. PubMed ID: 17559742
[TBL] [Abstract][Full Text] [Related]
9. Weight change and fractures in older women. Study of Osteoporotic Fractures Research Group.
Ensrud KE; Cauley J; Lipschutz R; Cummings SR
Arch Intern Med; 1997 Apr; 157(8):857-63. PubMed ID: 9129545
[TBL] [Abstract][Full Text] [Related]
10. Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program.
Leslie WD; Tsang JF; Lix LM
Bone; 2008 Oct; 43(4):667-71. PubMed ID: 18602504
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for fractures of the proximal humerus: results from the EPIDOS prospective study.
Lee SH; Dargent-Molina P; Bréart G;
J Bone Miner Res; 2002 May; 17(5):817-25. PubMed ID: 12009012
[TBL] [Abstract][Full Text] [Related]
12. Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: the Danish Osteoporosis Prevention Study.
Abrahamsen B; Vestergaard P; Rud B; Bärenholdt O; Jensen JE; Nielsen SP; Mosekilde L; Brixen K
J Bone Miner Res; 2006 May; 21(5):796-800. PubMed ID: 16734396
[TBL] [Abstract][Full Text] [Related]
13. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
14. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
[TBL] [Abstract][Full Text] [Related]
15. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).
Jakob F; Marín F; Martín-Mola E; Torgerson D; Fardellone P; Adami S; Thalassinos NC; Sykes D; Melo-Gomes J; Chinn C; Nicholson T; Cooper C
QJM; 2006 Aug; 99(8):531-43. PubMed ID: 16861718
[TBL] [Abstract][Full Text] [Related]
16. Low bone mineral density and fracture burden in postmenopausal women.
Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
[TBL] [Abstract][Full Text] [Related]
17. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.
Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM
Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644
[TBL] [Abstract][Full Text] [Related]
18. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
[TBL] [Abstract][Full Text] [Related]
19. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
20. A family history of fracture and fracture risk: a meta-analysis.
Kanis JA; Johansson H; Oden A; Johnell O; De Laet C; Eisman JA; McCloskey EV; Mellstrom D; Melton LJ; Pols HA; Reeve J; Silman AJ; Tenenhouse A
Bone; 2004 Nov; 35(5):1029-37. PubMed ID: 15542027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]